Pain News and Research

Latest Pain News and Research

CPS supports NACI recommendations for new shingles vaccine

The Canadian Pain Society (CPS) supports the National Advisory Committee on Immunization (NACI) recommendations for the use of a vaccine to significantly reduce the risk of developing herpes zoster (shingles) and post herpetic neuralgia in adults over the age of 60 without contraindications.

3 Feb 2010

One-third of doctors and diabetes patients prioritize health conditions differently

About one-third of doctors and their patients with diabetes do not see eye to eye on the most important health conditions to manage, according to a survey by the University of Michigan Medical School.

3 Feb 2010

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.

3 Feb 2010

MISI opens new comprehensive spine care facility in Las Colinas

The Minimally Invasive Spine Institute, one of the most advanced diagnostic and treatment facilities for back and neck pain as well as spinal disorders in the United States, has opened a comprehensive spine care facility in Las Colinas to offer both holistic and traditional approaches to spine care, advancing physician practices by forever changing the patient experience.

2 Feb 2010

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.

2 Feb 2010

Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

Gentag, Inc. and The CORE Institute® are pleased to announce the signing of a license agreement to develop and commercialize a disposable wireless skin patch to allow patients to self monitor themselves in the comfort of their homes after orthopedic surgery in hospitals through the use of cell phones

2 Feb 2010

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.

2 Feb 2010

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Recent data arising out of the Better Hearing Institute's "MarkeTrak" national study demonstrates that hearing loss is prevalent, serious, and often denied by the sufferer. The information revealed suggests that family members of the hearing impaired should actively encourage their loved ones to address their hearing problem, an effort which will greatly benefit both the hard of hearing and their kin.

2 Feb 2010

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

ZymoGenetics, Inc., today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in the February issue of the Journal of the American College of Surgeons. The authors concluded that RECOTHROM is a well-tolerated topical hemostatic agent in numerous surgical settings and has a low rate of anti-product antibody formation. In the pooled data from all trials, less than one percent of treated patients developed product-specific antibodies. None of the antibodies neutralized native coagulation proteins.

2 Feb 2010

Millennials overly optimistic about their health despite unhealthy habits

According to Life University, a leading chiropractic college and vital health university, Millennials (ages 15-27), are overly optimistic about their own health, despite admitting to the same unhealthy habits that have caused chronic illness in previous generations.

2 Feb 2010

Millennium Laboratories supports CLIA certification for Florida clinical laboratories

Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, today announced the company’s support for a recent decision by the Florida Pain Management Clinic Standards of Practice Joint Committee to amend draft regulatory language related to the certification of clinical laboratories providing services to pain physicians operating in the state.

2 Feb 2010

Majority of surgeons experience occupational injuries from minimally invasive techniques

Surgeons who engage in minimally invasive, laparoscopic surgery are providing great benefits to their patients, but possibly to their own detriment. That's the finding of the largest survey ever conducted of surgeons in North America who perform laparoscopic procedures.

2 Feb 2010

Strength of distal leg musculature contributes to SCK difficulty in older adults

Decreased muscle strength is associated with difficulty in performing functional activities such as stooping, crouching, or kneeling (SCK) in older adults, according to an observational study published in the January issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA). These researchers found that adults with SCK difficulty had significant decreases in adjusted strength measurements of trunk extensor, knee extensor, and ankle flexion muscles.

2 Feb 2010

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions.

2 Feb 2010

New approach may prove useful in labor anesthesia, orthopedics and more

One of the holy grails of local anesthesia is the ability to achieve a long-lasting nerve block that eliminates pain sensation while not affecting motor function. Now, researchers at Children's Hospital Boston have discovered an anesthetic approach that seems to do just that.

2 Feb 2010

Cardiac arrest sudden death: The seven warning signs

As Americans look to keep their fitness resolutions and increase their physical activity, Dr. Bing Liem, cardiologist and electrophysiologist at El Camino Hospital in Mountain View, Calif., is hoping to raise awareness of a critical but rare heart condition: congenital malformations of the heart or vascular system, which is to blame for the majority of sudden cardiac deaths in athletes under the age of 40.

2 Feb 2010

Loyola surgeon performs complicated laparoscopic procedure

Mild cases of diverticulitis can be treated with changes in diet, rest and antibiotics. However, Bunch's condition was more serious and the chances of recurrences were high. Her doctors at Loyola University Health System said her best option would be surgery to remove the inflamed section of colon.

2 Feb 2010

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo’s sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.

2 Feb 2010

Tips to ease prenatal back and neck pain from LSI

One of the most common discomforts experienced by women during pregnancy is back pain. Expectant mothers endure a variety of different types of backache as their hormones and posture change during pregnancy.

2 Feb 2010

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Phosphagenics Limited today announced positive results from a Phase 1B clinical study using the Company’s patented TPM™ (Targeted Penetration Matrix) for the transdermal delivery of oxycodone. The results of the successful trial demonstrate that daily application of a TPM™ patch delivers therapeutic levels of oxycodone into the blood stream in a reproducible, consistent and sustained manner.

2 Feb 2010

Pain News and Research

Latest Pain News and Research

CPS supports NACI recommendations for new shingles vaccine

One-third of doctors and diabetes patients prioritize health conditions differently

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

MISI opens new comprehensive spine care facility in Las Colinas

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Gentag signs license agreement to develop and commercialize post surgery wireless skin patch

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

Millennials overly optimistic about their health despite unhealthy habits

Millennium Laboratories supports CLIA certification for Florida clinical laboratories

Majority of surgeons experience occupational injuries from minimally invasive techniques

Strength of distal leg musculature contributes to SCK difficulty in older adults

Cardiac catheterization: A groundbreaking tool in the field of cardiology

New approach may prove useful in labor anesthesia, orthopedics and more

Cardiac arrest sudden death: The seven warning signs

Loyola surgeon performs complicated laparoscopic procedure

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Tips to ease prenatal back and neck pain from LSI

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Pain News and Research

Latest Pain News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in